Abstract
IntroductionObtaining level 1 evidence on efficacy of glycosaminoglycan (GAG) therapy is difficult, due to low incidence of bladder pain syndrome/interstitial cystitis (BPS/IC) and heterogeneous symptoms experienced by patients with BPS/IC....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have